Simulation results suggested CaMKII inhibitors (reduce the total amount of CaMKII or reduce its activity) lead to more stable and larger CaT amplitude, therefore can reduce the incidence of malignant arrhythmia and improve myocardial mechanical function, which may become an important treatment strategy for AF patients with HF. The gene discussed is CAT; the disease is hydrops fetalis.